Pharmacotherapy of schizophrenia.
D055598:Chemical Phenomena; D002621:Chemistry; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism; D004409:Dyskinesia, Drug-Induced / Q000209:etiology; D005128:Eye Diseases / Q000139:chemically induced; D006801:Humans; D008032:Limbic System / Q000187:drug effects; D010859:Pigmentation Disorders / Q000139:chemically induced; D011954:Receptors, Dopamine / Q000187:drug effects; D012559:Schizophrenia / Q000188:drug therapy*; D014149:Tranquilizing Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*
D011954:Receptors, Dopamine; D014149:Tranquilizing Agents; D004298:Dopamine